MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

87.49 -5.77

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

87.05

Max

92.81

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+41.06% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.9B

12B

Ankstesnė atidarymo kaina

93.26

Ankstesnė uždarymo kaina

87.49

Naujienos nuotaikos

By Acuity

50%

50%

168 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-08 20:44; UTC

Uždarbis

Costco Reports 11% Growth in March Sales

2026-04-08 23:51; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-08 23:51; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

2026-04-08 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Lower on Likely Technical Correction -- Market Talk

2026-04-08 22:56; UTC

Rinkos pokalbiai

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

2026-04-08 22:45; UTC

Rinkos pokalbiai

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

2026-04-08 22:17; UTC

Rinkos pokalbiai

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

2026-04-08 21:52; UTC

Svarbiausios naujienos

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

2026-04-08 21:24; UTC

Uždarbis

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

2026-04-08 21:01; UTC

Svarbiausios naujienos

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

2026-04-08 20:50; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2026-04-08 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

2026-04-08 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

2026-04-08 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

2026-04-08 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

2026-04-08 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

2026-04-08 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Responds to TRC Cap Mini-Tender Offer

2026-04-08 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-08 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

2026-04-08 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

2026-04-08 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

2026-04-08 19:44; UTC

Uždarbis

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

2026-04-08 19:16; UTC

Rinkos pokalbiai

Hogs Follow Cutout Prices Lower -- Market Talk

2026-04-08 19:02; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-04-08 19:02; UTC

Rinkos pokalbiai

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

2026-04-08 18:58; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

2026-04-08 18:51; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-08 18:51; UTC

Rinkos pokalbiai

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

2026-04-08 18:14; UTC

Svarbiausios naujienos

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

2026-04-08 18:05; UTC

Svarbiausios naujienos

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

41.06% į viršų

12 mėnesių prognozė

Vidutinis 131.61 USD  41.06%

Aukščiausias 175 USD

Žemiausias 90 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

19

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

168 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat